Neutrogena Faces Boycott Wave After Panettiere’s Death Resurfaces Contract Dispute

Fans are launching a coordinated boycott of Neutrogena following the death of Hayden Panettiere, which has revived her claims that the skincare brand terminated her decade-long endorsement deal after she publicly discussed postpartum depression. The backlash has driven a significant spike in search interest and social media engagement, while the parent company, Kenvue Inc., saw its stock dip. Neutrogena has not issued a public response to the renewed criticism or the specific allegations regarding the contract termination.
Key points
- Hayden Panettiere died on August 16, 2026, at age 36, prompting fans to revisit her 2015 claims that Neutrogena dropped her after she disclosed her mental health struggles.
- Panettiere stated in a recent interview and her memoir 'This Is Me: A Reckoning' that the brand canceled her contract after she spoke about postpartum depression on live television.
- The term 'Neutrogena boycott' has seen a 5,000% increase in search trends over three days, with over 70,000 calls for a brand ban on TikTok.
- Kenvue Inc., the parent company of Neutrogena, experienced a stock price drop of over 2% following the renewed controversy.
- Neutrogena has not publicly addressed the allegations or the boycott, though the company is currently offering discounts at retail partners like Ulta Beauty.
Background
This controversy resurfaces a long-standing debate about the intersection of celebrity endorsement contracts and workplace protections for mental health. While federal laws like the Americans with Disabilities Act offer protections for employees, celebrity contracts are typically governed by private agreements that may not include the same safeguards. The recent death of Panettiere has intensified public scrutiny of how brands handle ambassadors who disclose personal health crises, particularly in the context of maternal mental health.
How outlets are covering it
Complex and The Independent focus on the legal and contractual nuances, noting that while Panettiere’s situation highlights the risks for celebrities, no legal action was taken and the contract was likely governed by private terms rather than standard employment law. The New York Post emphasizes the consumer reaction, highlighting the massive surge in boycott calls and the immediate impact on Kenvue’s stock. All sources agree that Neutrogena has remained silent on the matter, though the New York Post notes a separate, unrelated scandal involving brand ambassador Tate McRae earlier in the month.
Why it matters
The incident underscores the ongoing tension between corporate brand management and public advocacy for mental health. It highlights how private endorsement contracts can leave individuals without the protections afforded to standard employees, while also demonstrating the power of social media in driving immediate financial and reputational consequences for major consumer brands.
What to watch
Investigations into the cause of Panettiere’s death are ongoing, with authorities confirming no foul play. Neutrogena is expected to face continued pressure from consumers and potentially from regulatory bodies if the boycott gains sustained traction. The company may issue a statement or adjust its marketing strategies in response to the sustained negative sentiment.
- Neutrogena Faces New Backlash After Hayden Panettiere’s Death Complex
- Neutrogena’s stock spirals after Hayden Panettiere’s tragic death as fans vow to boycott: ‘I will never buy again’ New York Post
- Neutrogena faces renewed backlash after Hayden Panettiere’s death The Independent
- Mary McNamara: By speaking her truth, Hayden Panettiere broke the silence around postpartum depression UnionLeader.com
- Neutrogena faces backlash after Hayden Panettiere’s death—how the brand should respond Ad Age
Want the full story? Read the original reporting
Read on Complex